MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jot.2026.101146

Медицинская библиотека · Journal of orthopaedic translation · 2026

GFRα2 identified in TBI-induced bone healing is a novel therapeutic target for osteoporosis via osteogenesis and angiogenesis.

Ti Huibo, Zhang Zhenyu, Kang Huaxin, Chen Yuechun, Zhang Keyue, Shi Shuwen, Wu Xian, Luo Zixin, Yao Xingchen, Yan Xielin, Wu Junjie, Yuan Zhengdong, Nie Hao, Yuan Feng-Lai, Li Xia

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Osteoporosis (OP) is a systemic disease featured by reduced bone mass, deteriorated microstructure and elevated fracture risk. Traditional therapies mainly target direct regulators of bone remodeling. Emerging evidence suggests a critical crosstalk between the skeletal and nervous systems. Traumatic brain injury (TBI) markedly accelerates fracture healing, which holds great potential for OP treatment, yet the underlying mechanism remains unclear.

METHODS

A mouse TBI plus femoral fracture model was established. Micro-CT, histomorphometry and transcriptome sequencing were performed. In vitro studies included qPCR, Western blot, ALP/Alizarin Red staining, co-culture, ELISA and tube formation assays. Ovariectomized (OVX) mice received tail vein injection of Gfrα2 overexpression plasmid or siRNA for in vivo validation.

RESULTS

TBI significantly accelerated fracture healing with elevated GFRα2 in callus BMSCs. GFRα2 promoted BMSC osteogenesis by maintaining iron homeostasis via Ferritin Heavy Chain 1 (FTH1) and enhanced angiogenesis by increasing VEGFD secretion. In OVX mice, GFRα2 overexpression markedly improved bone mineral density, trabecular microstructure, bone formation rate and intraosseous angiogenesis.

CONCLUSIONS

GFRα2 serves as a key hub linking TBI to accelerated bone formation via dual effects on osteogenesis and angiogenesis. Targeting GFRα2 represents a promising therapeutic strategy against osteoporosis.

THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: This study identifis GFRα2 as a key mediator linking traumatic brain injury-accelerated bone formation to osteogenesis and angiogenesis. Targeting GFRα2 effectively ameliorates bone loss in osteoporotic mice by restoring both bone formation and intraosseous vascularization. These findings establish a novel neuro-osteogenic regulatory axis and provide a promising molecular target for developing new therapeutic strategies to treat osteoporosis and improve fracture healing in clinical practice.

Для цитирования: Ti Huibo, Zhang Zhenyu, Kang Huaxin, Chen Yuechun, Zhang Keyue, Shi Shuwen, Wu Xian, Luo Zixin, Yao Xingchen, Yan Xielin, Wu Junjie, Yuan Zhengdong, Nie Hao, Yuan Feng-Lai, Li Xia. GFRα2 identified in TBI-induced bone healing is a novel therapeutic target for osteoporosis via osteogenesis and angiogenesis.. Journal of orthopaedic translation. 2026. DOI: 10.1016/j.jot.2026.101146.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.